Trial NCT04953052

View at ClinicalTrials.gov 
Org. Study IDs: EX003
Secondary IDs: 959310

Last trial update was posted on 2022-07-28

MeSH Interventions

Imatinib Mesylate

MeSH Conditions

Acute Lung Injury COVID-19 Pulmonary Edema Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Syndrome

Other Conditions

ARDS Acute Respiratory Distress Syndrome COVID-19 Acute Respiratory Distress Syndrome Covid19 Pulmonary Oedema

Stopping Reasons

Number of moderate to severe ARDS patients hospitalised due to COVID19 diminishingly small. Not expected to recruit required minimum number of patients.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID